ArticleToxins2026
Ligand Screening for Enzyme Immobilization Enables Efficient Removal of Aflatoxin B1 in Continuous Flow System.
Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Aflatoxin B1 (AFB1) contamination is a significant issue for the safety of edible oils. Biodegradation of mycotoxins represents a green and efficient approach. However, enzymes exhibit low catalytic activity and stability under harsh conditions, leading to rapid deactivation in edible oils. Zeolitic imidazolate frameworks (ZIFs) possess high specific surface areas, tunable pore sizes, and excellent thermal stability. Immobilizing enzymes on ZIFs can address the problem of enzyme inactivation during application. Although the stability of the enzyme can be enhanced after immobilization, the overall enzymatic activity remains limited. To overcome the issues of low catalytic activity and poor cycling stability associated with enzymes immobilized on ZIF-8 using 2-methylimidazole (2-mIM) as the ligand, this study optimized the ZIF structure through a ligand screening strategy. Both encapsulation efficiency and cycling stability were enhanced. This research found that the activity of Lac@ZIFs(IM), which uses imidazole (IM) as the ligand, was 2.16 times that of Lac@ZIF-8. The degradation efficiency of AFB1 reached 93% within 4 h in edible oil using Lac@ZIFs(IM) as the catalyst, which was 21-fold higher than that of free laccase. Lac@ZIFs(IM) exhibited excellent activity in the continuous flow system. After 20 h of continuous reaction, the activity of Lac@ZIFs(IM) was 6.6 times that of Lac@ZIF-8. This study provides a novel approach for the efficient enzymatic degradation of mycotoxins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.